150 related articles for article (PubMed ID: 22178505)
21. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
Jang JW; Chun JY; Park YM; Shin SK; Yoo W; Kim SO; Hong SP
Cancer Sci; 2012 Feb; 103(2):296-304. PubMed ID: 22136288
[TBL] [Abstract][Full Text] [Related]
22. [Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells].
Liu XH; Lin J; Cao XZ; Zheng JM; Chen Y; Zhu MH
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):825-30. PubMed ID: 15949399
[TBL] [Abstract][Full Text] [Related]
23. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
24. Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus.
Tamori A; Nishiguchi S; Kubo S; Koh N; Moriyama Y; Fujimoto S; Takeda T; Shiomi S; Hirohashi K; Kinoshita H; Otani S; Kuroki T
Hepatology; 1999 May; 29(5):1429-34. PubMed ID: 10216126
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
[TBL] [Abstract][Full Text] [Related]
26. COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma.
Liu XH; Lin J; Zhang SH; Zhang SM; Feitelson MA; Gao HJ; Zhu MH
World J Gastroenterol; 2008 Mar; 14(9):1346-52. PubMed ID: 18322946
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
Zhang X; Dong N; Yin L; Cai N; Ma H; You J; Zhang H; Wang H; He R; Ye L
J Med Virol; 2005 Nov; 77(3):374-81. PubMed ID: 16173017
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH
Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537
[TBL] [Abstract][Full Text] [Related]
29. Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma.
Hsia CC; Nakashima Y; Tabor E
Biochem Biophys Res Commun; 1997 Dec; 241(3):726-9. PubMed ID: 9434776
[TBL] [Abstract][Full Text] [Related]
30. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
Zhang X; Dong N; Zhang H; You J; Wang H; Ye L
J Lab Clin Med; 2005 Feb; 145(2):98-104. PubMed ID: 15746653
[TBL] [Abstract][Full Text] [Related]
31. X gene mutations in hepatitis B patients with cirrhosis, with and without hepatocellular carcinoma.
Choi CS; Cho EY; Park R; Kim SJ; Cho JH; Kim HC
J Med Virol; 2009 Oct; 81(10):1721-5. PubMed ID: 19697408
[TBL] [Abstract][Full Text] [Related]
32. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
33. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
Tu H; Gao HF; Ma GH; Liu Y
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
[TBL] [Abstract][Full Text] [Related]
34. Distinctive gene expression profiles associated with Hepatitis B virus x protein.
Wu CG; Salvay DM; Forgues M; Valerie K; Farnsworth J; Markin RS; Wang XW
Oncogene; 2001 Jun; 20(28):3674-82. PubMed ID: 11439330
[TBL] [Abstract][Full Text] [Related]
35. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea.
Song BC; Kim H; Kim SH; Cha CY; Kook YH; Kim BJ
J Med Virol; 2005 Jan; 75(1):13-9. PubMed ID: 15543574
[TBL] [Abstract][Full Text] [Related]
36. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
Toyoda H; Kumada T; Kaneoka Y; Murakami Y
J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
[TBL] [Abstract][Full Text] [Related]
37. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
38. Involvement of hepatitis B virus X gene (HBx) integration in hepatocarcinogenesis via a recombination of HBx/Alu core sequence/subtelomeric DNA.
Zhang X; You X; Li N; Zhang W; Gagos S; Wang Q; Banos A; Cai N; Zhang H; Zhang H; Zhang X; Shan C; Qiu L; Zhang S; Lv N; Chen M; Du Y; Xia J; Ye L; Zhang X
FEBS Lett; 2012 Sep; 586(19):3215-21. PubMed ID: 22771476
[TBL] [Abstract][Full Text] [Related]
39. The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice.
Cui F; Wang Y; Wang J; Wei K; Hu J; Liu F; Wang H; Zhao X; Zhang X; Yang X
Proteomics; 2006 Jan; 6(2):498-504. PubMed ID: 16317774
[TBL] [Abstract][Full Text] [Related]
40. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
